Contact
Please use this form to send email to PR contact of this press release:
Hagens Berman Advises PTC Therapeutics (NASDAQ: PTCT) Investors of May 2, 2016 Lead Plaintiff Deadline in a Newly Filed Class Action
TO:
Please use this form to send email to PR contact of this press release:
Hagens Berman Advises PTC Therapeutics (NASDAQ: PTCT) Investors of May 2, 2016 Lead Plaintiff Deadline in a Newly Filed Class Action
TO: